Gefitinib improves severe bronchorrhea and prolongs the survival of a patient with lung invasive mucinous adenocarcinoma: A case report

Figure 1  Image shows 700 mL/d watery sputum produced by the patient.

Figure 2 Chest computed tomography findings. A: At the beginning of treatment; B: Anti-infection treatment lasted for 1 wk; C: Gefitinib was treated for 1 mo; D: Gefitinib was treated for 11 mo. Chest high-resolution computed tomography scan shows large flaky hyperintense shadows in both lungs, especially in the right lung. A-D show the chest computed tomography images at the first diagnosis, after anti-infection treatment for 1 wk, after treatment with gefitinib for 1 mo, and after treatment with gefitinib for 11 mo, respectively.

Figure 3 Bronchoscopy findings of the case. There are a lot of white secretions in the trachea.

Figure 4  Histopathological section of computed tomography -guided percutaneous lung biopsy specimen showing lung invasive mucinous adenocarcinoma (H&E stain, 200×).